Drugs / HIV-1 Peptide Vaccine, Microparticulate Monovalent
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00000798 | — | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00002428 | — | HIV infectious disease | United Biomedical | Completed | No outcome recorded |
| Phase 1 | NCT00000846 | — | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HIV-1 Peptide Vaccine, Microparticulate Monovalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000798 ↗ |
| Modality | Vaccine | “oral microparticulate vaccine” NCT00000798 ↗ |
| Route | Oral | “for oral administration” NCT00000798 ↗ |